United Laboratories Keeps Issued Share Capital Steady at 1.97 Billion in March 2026 Monthly Return

Bulletin Express04-02

The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the month.

• Authorised share capital: 3.80 billion ordinary shares with a par value of HKD 0.01 each, equal to HKD 38.00 million. There was no increase or decrease from the prior month.

• Issued share capital: 1,973,026,508 ordinary shares outstanding, with no treasury shares held. The total issued share count was identical to the balance at the end of February 2026, indicating no new issuance, cancellation, or buy-back activity.

• Public float: The company confirmed compliance with the Main Board’s minimum 25 % public float requirement as of 31 March 2026.

No share options, warrants, convertible instruments, or other agreements to issue shares were outstanding or exercised during the month, and there were no Hong Kong Depositary Receipt movements. The filing was authorised by Company Secretary Leung Wing Hon and submitted to Hong Kong Exchanges and Clearing Limited on 2 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166178711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166178711","market":"hk","top_or_hot":-1,"title":"United Laboratories Keeps Issued Share Capital Steady at 1.97 Billion in March 2026 Monthly Return","media":"Bulletin Express","content":"<p>The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the month.</p>\n<p>• Authorised share capital: 3.80 billion ordinary shares with a par value of HKD 0.01 each, equal to HKD 38.00 million. There was no increase or decrease from the prior month.</p>\n<p>• Issued share capital: 1,973,026,508 ordinary shares outstanding, with no treasury shares held. The total issued share count was identical to the balance at the end of February 2026, indicating no new issuance, cancellation, or buy-back activity.</p>\n<p>• Public float: The company confirmed compliance with the Main Board’s minimum 25 % public float requirement as of 31 March 2026.</p>\n<p>No share options, warrants, convertible instruments, or other agreements to issue shares were outstanding or exercised during the month, and there were no Hong Kong Depositary Receipt movements. The filing was authorised by Company Secretary Leung Wing Hon and submitted to Hong Kong Exchanges and Clearing Limited on 2 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>United Laboratories Keeps Issued Share Capital Steady at 1.97 Billion in March 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnited Laboratories Keeps Issued Share Capital Steady at 1.97 Billion in March 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the month.</p>\n<p>• Authorised share capital: 3.80 billion ordinary shares with a par value of HKD 0.01 each, equal to HKD 38.00 million. There was no increase or decrease from the prior month.</p>\n<p>• Issued share capital: 1,973,026,508 ordinary shares outstanding, with no treasury shares held. The total issued share count was identical to the balance at the end of February 2026, indicating no new issuance, cancellation, or buy-back activity.</p>\n<p>• Public float: The company confirmed compliance with the Main Board’s minimum 25 % public float requirement as of 31 March 2026.</p>\n<p>No share options, warrants, convertible instruments, or other agreements to issue shares were outstanding or exercised during the month, and there were no Hong Kong Depositary Receipt movements. The filing was authorised by Company Secretary Leung Wing Hon and submitted to Hong Kong Exchanges and Clearing Limited on 2 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"","article_id":"1166178711","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166178711","pubTimestamp":1775141036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03933":"联邦制药"},"translate_title":"联邦制药2026年3月已发行股本稳定在19.7亿美元月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1},"content_text":"The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the month.\n• Authorised share capital: 3.80 billion ordinary shares with a par value of HKD 0.01 each, equal to HKD 38.00 million. There was no increase or decrease from the prior month.\n• Issued share capital: 1,973,026,508 ordinary shares outstanding, with no treasury shares held. The total issued share count was identical to the balance at the end of February 2026, indicating no new issuance, cancellation, or buy-back activity.\n• Public float: The company confirmed compliance with the Main Board’s minimum 25 % public float requirement as of 31 March 2026.\nNo share options, warrants, convertible instruments, or other agreements to issue shares were outstanding or exercised during the month, and there were no Hong Kong Depositary Receipt movements. The filing was authorised by Company Secretary Leung Wing Hon and submitted to Hong Kong Exchanges and Clearing Limited on 2 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166178711","isCrawlerRequest":true}